• Alleviated hepatic steatosis in tumor-bearing, cachectic animals • Increased free fatty acid oxidation and ketogenesis • Enhanced VLDL secretion • Reduced peripheral lipoprotein lipase activity. The gene discussed is LPL; the disease is fatty liver disease.